FS.COM (03355.HK) said the trustee bought 370,000 H shares under its H-share award scheme at an average of HK$37.491, for a total of about HK$13.87 million.
OCUMENSION-B (01477.HK) said the NMPA approved mainland China production of its fluocinolone acetonide intravitreal implant, adding a domestic supply source.
IDREAMSKY (01119.HK) cut the conversion price of its HK$386 million 5.00% convertible bonds due 2028 from HK$3.58 to HK$3.51, effective 27 October 2026.
ZHONG JI LS (00767.HK) signed a fourth supplemental agreement on its 25% Asia Integrated Cell Bank deal, moving debt repayment to nine months after completion.
IDREAMSKY (01119.HK) placed 187,856,000 new shares at HK$0.31, raising net proceeds of about HK$56.63 million for AI agent development and game operations.
SCHOLAR EDU (01769.HK) said the trustee bought 297,000 shares under the award scheme at an average HK$0.71, lifting its holding to 53,440,000, or 7.93%.
CICC (03908.HK) closed on 26 October 2026 its share-swap merger of Dongxing Securities and Cinda Securities, taking over their assets and outstanding bonds.
QINGCI GAMES (06633.HK) lent chairman Yang Xu and CEO Huang Zhiqiang up to RMB46 million and RMB4 million at 3.2% for personal financial arrangements.
ESTUN (02715.HK) will buy a 19.4574% stake in Estun Jiangsu Intelligent for RMB210.6 million, raising its holding to 69.608%; the target remains a subsidiary.
CSPC PHARMA (01093.HK) reported SYS6043 Phase I/II data at ESMO 2026, with ORR of 75.0% in TNBC, 69.6% in HER2+ and 53.7% in HR+/HER2- breast cancer.
CSPC PHARMA (01093.HK) said SYS6090 Phase I/II data in advanced solid tumours presented at ESMO 2026; ORR 40.0% in HCC, 21.1% in CRC and over 30.0% in NSCLC.
TIANGONG INT'L (00826.HK) said its unit won a bid to supply about 4 tonnes of powder metallurgy high-boron steel parts for the BEST device at RMB2.376 million.
CITIC BANK (00998.HK) completed the redemption and delisting of its RMB35 billion preference shares, paying RMB36.428 billion in nominal value and dividends.
October 27, 2026, SHANDONG MOLONG(00568.HK) released its Nine-Month Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.77 billion, increased by 48.05% YoY.
GRAPHEX GROUP (06128.HK) placed 188.26 million new shares at HK$0.050 each for net proceeds of about HK$8.9 million, and cut warrant exercise price to HK$0.05.
SUNEVISION (01686.HK) issued 1,719,427,500 shares to SHKP Group on note conversion, leaving a 15.10% public float, so it adopts the 10% alternative threshold.
